StockNews.AI

OneMedNet Delivers a Real-World Data feed of 1.5M Patients consisting of 4M encounters

StockNews.AI • 1 minute

AMZNCRMPALANTIR
High Materiality8/10

Information

MINNEAPOLIS, Jan. 16, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provi...

Original source

AI Summary

ONMD delivered 1.5 million patients' data to a top healthcare analytics organization. This dataset supports enterprise-scale validation and boosts commercial capabilities. The subscription model enhances recurring revenue and long-term partnerships. The data delivery enhances ONMD's market position among healthcare data providers. CEO highlights the importance of rich, Real-World Data for life sciences partners.

Sentiment Rationale

The successful data delivery reinforces ONMD's business model and commercial viability, similar to Amazon's shift to subscription services which significantly bolstered revenue.

Trading Thesis

The transition to a subscription model typically results in stable income streams, akin to other tech firms like Salesforce which grew through recurring revenues.

Market-Moving

  • ONMD delivered 1.5 million patients' data to a top healthcare analytics organization.
  • This dataset supports enterprise-scale validation and boosts commercial capabilities.
  • The subscription model enhances recurring revenue and long-term partnerships.

Key Facts

  • ONMD delivered 1.5 million patients' data to a top healthcare analytics organization.
  • This dataset supports enterprise-scale validation and boosts commercial capabilities.
  • The subscription model enhances recurring revenue and long-term partnerships.
  • The data delivery enhances ONMD's market position among healthcare data providers.
  • CEO highlights the importance of rich, Real-World Data for life sciences partners.

Companies Mentioned

  • AMZN (AMZN)
  • CRM (CRM)
  • PALANTIR (PALANTIR)

Corporate Developments

The successful delivery of data indicates strong demand and positions ONMD favorably in the competitive healthcare data landscape.

OneMedNet Announces Major Milestone with Delivery of 1.5 Million Patient Real-World Data Feed

MINNEAPOLIS, Jan. 16, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a premier provider of regulatory-grade and AI-ready Real-World Data (RWD), has successfully delivered a vital anonymized Real-World Data feed comprising 1.5 million patients and 4 million encounters to a leading healthcare data organization. This significant delivery aligns with OneMedNet's subscription model, facilitating enterprise-scale testing and validation for prominent industry players in pharmaceuticals, biotechnology, and medical device manufacturing.

Significance of Real-World Data Delivery

The newly delivered data feed encompasses over 1.49 billion data points of structured and unstructured data, allowing for comprehensive longitudinal clinical analysis. The dataset includes critical elements such as:

  • Practitioner notes
  • Immunizations
  • Health conditions
  • Medications
  • Patient encounters
  • Clinical observations

This multimodal dataset not only affirms OneMedNet's capability for advanced analytics and regulatory-grade research but also enhances the potential for AI-driven healthcare applications, thereby paving the way for future innovations.

Transitioning to Recurring Revenue Models

OneMedNet highlights that this achievement further substantiates its subscription model, which provides clients with continuous and on-demand access to refreshed Real-World Data. The company aims to convert one-time transactions into predictable annual recurring revenue (ARR) streams, thus fostering long-term, high-value partnerships.

“Life sciences and data platform partners require Real-World Data at scale, sufficiently rich to capture real clinical complexity,” said Aaron Green, CEO and President of OneMedNet. “Delivering a 1.5 million patient, multimodal dataset under our subscription model demonstrates our commitment to supporting enterprise validation today while advancing subscription-based data feeds that create durable, long-term value.”

Empowering the Healthcare Data Ecosystem

Utilizing Palantir's AIP Foundry, OneMedNet’s platform is designed to assist data aggregators, life sciences organizations, and technical partners in mitigating integration risks, expediting time-to-market, and enhancing the commercialization of Real-World Evidence (RWE). Following this successful validation and with additional clients in the pipeline, OneMedNet is well-positioned to broaden its healthcare data ecosystem further.

About OneMedNet Corporation

OneMedNet is at the forefront of revolutionizing access to Real-World Data (RWD), leveraging over 2,130 healthcare sites through its innovative iRWD™ platform. This platform is integral to breakthroughs in drug development and medical device innovation, offering precision insights across a wide range of clinical areas, including oncology, cardiology, and rare diseases.

Expanding its capabilities beyond healthcare, OneMedNet also anonymizes data for other sectors such as finance, retail, and telecommunications, ensuring secure data sharing and rigorous testing of production systems.

Forward-Looking Statements

This release contains forward-looking statements as defined in the Securities Act of 1933 and the Securities Exchange Act of 1934. These statements encompass projections regarding OneMedNet's operational strategies and product offerings. Risks include market uncertainties and technological challenges that may affect results.

Related News